ID: MRFR/LS/0344-HCR | 105 Pages | Published By Rahul Gotadki on March 2023
Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Biologic Therapy Market, by Product Type
6.1 Introduction
6.2 Kits & Reagents
6.2.1 Market Estimates & Forecast, 2023-2030
6.3 Services
6.3.1 Market Estimates & Forecast, 2023-2030
6.4 Instruments
6.4.1 Market Estimates & Forecast, 2023-2030
7. Global Biologic Therapy Market, by Therapy
7.1 Introduction
7.2 Protein Therapy
7.2.1 Market Estimates & Forecast, 2023-2030
7.3 Vaccines Therapy
7.3.1 Market Estimates & Forecast, 2023-2030
7.4 Cell Therapy
7.4.1 Market Estimates & Forecast, 2023-2030
7.5 Others
7.5.1 Market Estimates & Forecast, 2023-2030
8. Global Biologic Therapy Market, by Application
8.1 Introduction
8.2 Vaccine & Therapeutics Development
8.2.1 Market Estimates & Forecast, 2023-2030
8.3 Blood and Blood-Related Products Testing
8.3.1 Market Estimates & Forecast, 2023-2030
8.4 Cellular and Gene Therapy
8.4.1 Market Estimates & Forecast, 2023-2030
8.4 Tissue and Tissue-Related Products Testing
8.4.1 Market Estimates & Forecast, 2023-2030
8.4 Stem Cell Research
8.4.1 Market Estimates & Forecast, 2023-2030
9. Global Biologic Therapy Market, by End-User
9.1 Introduction
9.2 Hospitals & Clinics
9.2.1 Market Estimates & Forecast, 2023-2030
9.3 Specialty Centers
9.3.1 Market Estimates & Forecast, 2023-2030
9.4 Research Centers
9.4.1 Market Estimates & Forecast, 2023-2030
10 Global Biologic Therapy Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K.
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Amgen Inc.
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Bristol-Myers Squibb
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Celgene Corporation
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 F. Hoffmann-La Roche AG
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Novartis International AG
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 GlaxoSmithKline Plc
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Seattle Genetics, Inc.
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pharmaceutical Industry
14 Appendix
LIST OF TABLES
Table 1 Prescribed Biologic Therapy Industry Synopsis, 2023-2030
Table 2 Global Biologic Therapy Market Estimates and Forecast, 2023-2030, (USD Million)
Table 3 Global Biologic Therapy Market, by Region, 2023-2030, (USD Million)
Table 5 Global Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 6 Global Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 7 Global Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 8 North America Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 9 North America Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 10 North America Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 11 US Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 12 US Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 13 US Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 14 Canada Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 15 Canada Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 16 Canada Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 17 South America Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 18 South America Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 19 South America Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 20 Europe Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 21 Europe Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 22 Europe Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 23 Western Europe Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 24 Western Europe Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 25 Western Europe Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 26 Eastern Europe Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 27 Eastern Europe Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 28 Eastern Europe Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 29 Asia Pacific Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 30 Asia Pacific Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 31 Asia Pacific Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
Table 32 Middle East & Africa Biologic Therapy Market, by Type, 2023-2030, (USD Million)
Table 33 Middle East & Africa Biologic Therapy Market, by Application, 2023-2030, (USD Million)
Table 34 Middle East & Africa Biologic Therapy Market, by End-User, 2023-2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Biologic Therapy Market
Figure 3 Segmentation Market Dynamics for Biologic Therapy Market
Figure 4 Global Biologic Therapy Market Share, by Type 2023
Figure 5 Global Biologic Therapy Market Share, by Application 2023
Figure 6 Global Biologic Therapy Market Share, by End-User, 2023
Figure 7 Global Biologic Therapy Market Share, by Region, 2023
Figure 8 North America Biologic Therapy Market Share, by Country, 2023
Figure 9 Europe Biologic Therapy Market Share, by Country, 2023
Figure 10 Asia Pacific Biologic Therapy Market Share, by Country, 2023
Figure 11 Middle East & Africa Biologic Therapy Market Share, by Country, 2023
Figure 12 Global Biologic Therapy Market: Company Share Analysis, 2023 (%)
Figure 13 Amgen Inc.: Key Financials
Figure 14 Amgen Inc.: Segmental Revenue
Figure 16 Amgen Inc.: Geographical Revenue
Figure 17 Celgene Corporation: Key Financials
Figure 18 Celgene Corporation: Segmental Revenue
Figure 19 Celgene Corporation: Geographical Revenue
Figure 20 Novartis International AG: Key Financials
Figure 21 Novartis International AG Segmental Revenue
Figure 22 Novartis International AG: Geographical Revenue
Figure 23 Seattle Genetics, Inc.: Key Financials
Figure 24 Seattle Genetics, Inc.: Segmental Revenue
Figure 25 Seattle Genetics, Inc.: Geographical Revenue
Figure 26 Spectrum Pharmaceuticals, Inc.: Key Financials
Figure 27 Spectrum Pharmaceuticals, Inc.: Segmental Revenue
Figure 28 Spectrum Pharmaceuticals, Inc.: Geographical Revenue
Figure 29 GlaxoSmithKline Plc. Key Financials
Figure 30 GlaxoSmithKline Plc. Segmental Revenue
Figure 31 GlaxoSmithKline Plc. Geographical Revenue
Figure 32 Stryker: Key Financials
Figure 33 Stryker: Segmental Revenue
Figure 34 Stryker: Geographical Revenue
Biologic Therapy Market Segmentation
Biologic Therapy Product Type Outlook (USD Billion, 2019-2030)
Â
Kits & Reagents
Services
Â
Biologic Therapy Therapy Outlook (USD Billion, 2019-2030)
Â
Protein Therapy
Vaccines Therapy
Â
Biologic Therapy Application Outlook (USD Billion, 2019-2030)
Â
Cellular
Gene Therapy
Â
Biologic Therapy End User Outlook (USD Billion, 2019-2030)
Â
Hospitals
Clinics
Specialty Centers
Â
Biologic Therapy Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
Â
North America Biologic Therapy by Product Type
Kits & Reagents
Services
North America Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
North America Biologic Therapy by Application
Cellular
Gene Therapy
North America Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
US Outlook (USD Billion, 2019-2030)
US Biologic Therapy by Product Type
Kits & Reagents
Services
US Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
US Biologic Therapy by Application
Cellular
Gene Therapy
US Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
CANADA Outlook (USD Billion, 2019-2030)
CANADA Biologic Therapy by Product Type
Kits & Reagents
Services
CANADA Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
CANADA Biologic Therapy by Application
Cellular
Gene Therapy
CANADA Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Â
Europe Outlook (USD Billion, 2019-2030)
Â
Europe Biologic Therapy by Product Type
Kits & Reagents
Services
Europe Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
Europe Biologic Therapy by Application
Cellular
Gene Therapy
Europe Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Germany Outlook (USD Billion, 2019-2030)
Germany Biologic Therapy by Product Type
Kits & Reagents
Services
Germany Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
Germany Biologic Therapy by Application
Cellular
Gene Therapy
Germany Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
France Outlook (USD Billion, 2019-2030)
France Biologic Therapy by Product Type
Kits & Reagents
Services
France Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
France Biologic Therapy by Application
Cellular
Gene Therapy
France Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
UK Outlook (USD Billion, 2019-2030)
UK Biologic Therapy by Product Type
Kits & Reagents
Services
UK Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
UK Biologic Therapy by Application
Cellular
Gene Therapy
UK Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
ITALY Outlook (USD Billion, 2019-2030)
ITALY Biologic Therapy by Product Type
Kits & Reagents
Services
ITALY Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
ITALY Biologic Therapy by Application
Cellular
Gene Therapy
ITALY Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
SPAIN Outlook (USD Billion, 2019-2030)
Spain Biologic Therapy by Product Type
Kits & Reagents
Services
Spain Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
Spain Biologic Therapy by Application
Cellular
Gene Therapy
Spain Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Rest of Europe Outlook (USD Billion, 2019-2030)
Rest of Europe Biologic Therapy by Product Type
Kits & Reagents
Services
REST OF EUROPE Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
REST OF EUROPE Biologic Therapy by Application
Cellular
Gene Therapy
REST OF EUROPE Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Â
Asia-Pacific Outlook (USD Billion, 2019-2030)
Â
Asia-Pacific Biologic Therapy by Product Type
Kits & Reagents
Services
Asia-Pacific Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
Asia-Pacific Biologic Therapy by Application
Cellular
Gene Therapy
Asia-Pacific Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
China Outlook (USD Billion, 2019-2030)
China Biologic Therapy by Product Type
Kits & Reagents
Services
China Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
China Biologic Therapy by Application
Cellular
Gene Therapy
China Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Japan Outlook (USD Billion, 2019-2030)
Japan Biologic Therapy by Product Type
Kits & Reagents
Services
Japan Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
Japan Biologic Therapy by Application
Cellular
Gene Therapy
Japan Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
India Outlook (USD Billion, 2019-2030)
India Biologic Therapy by Product Type
Kits & Reagents
Services
India Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
India Biologic Therapy by Application
Cellular
Gene Therapy
India Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Australia Outlook (USD Billion, 2019-2030)
Australia Biologic Therapy by Product Type
Kits & Reagents
Services
Australia Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
Australia Biologic Therapy by Application
Cellular
Gene Therapy
Australia Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Biologic Therapy by Product Type
Kits & Reagents
Services
Rest of Asia-Pacific Biologic Therapy by Therapy
Protein Therapy
Vaccines Therapy
Rest of Asia-Pacific Biologic Therapy by Application
Cellular
Gene Therapy
Rest of Asia-Pacific Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers
Â
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Biologic Therapy by Product Type
Â
Kits & Reagents
Services
Â
Rest of the World Biologic Therapy by Therapy
Â
Protein Therapy
Vaccines Therapy
Â
Rest of the World Biologic Therapy by Application
Â
Cellular
Gene Therapy
Â
Rest of the World Biologic Therapy by End User
Â
Hospitals
Clinics
Specialty Centers
Â
Middle East Outlook (USD Billion, 2019-2030)
Middle East Biologic Therapy by Product Type
Â
Kits & Reagents
Services
Â
Middle East Biologic Therapy by Therapy
Â
Protein Therapy
Vaccines Therapy
Â
Middle East Biologic Therapy by Application
Â
Cellular
Gene Therapy
Â
Middle East Biologic Therapy by End User
Â
Hospitals
Clinics
Specialty Centers
Â
Africa Outlook (USD Billion, 2019-2030)
Africa Biologic Therapy by Product Type
Â
Kits & Reagents
Services
Â
Africa Biologic Therapy by Therapy
Â
Protein Therapy
Vaccines Therapy
Â
Africa Biologic Therapy by Application
Â
Cellular
Gene Therapy
Â
Africa Biologic Therapy by End User
Â
Hospitals
Clinics
Specialty Centers
Â
Latin America Outlook (USD Billion, 2019-2030)
Latin America Biologic Therapy by Product Type
Â
Kits & Reagents
Services
Â
Latin America Biologic Therapy by Therapy
Â
Protein Therapy
Vaccines Therapy
Â
Latin America Biologic Therapy by Application
Â
Cellular
Gene Therapy
Â
Latin America Biologic Therapy by End User
Hospitals
Clinics
Specialty Centers